Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lipoprotein classes and coronary disease regression

A Zambon1, J E Hokanson

  • 1Department of Medicine, University of Washington School of Medicine, Seattle, USA. iodza@tin.it

Current Opinion in Lipidology
|September 18, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Screening performance of the FINDRISC score for identification of undiagnosed type 2 diabetes in persons with severe obesity.

Diabetology & metabolic syndrome·2026
Same author

Corrigendum to "Implementing Occupational Therapy into an Acute Geriatric Ward: Effects on Patients' Functional Status at Discharge" [J Frailty Aging 13 (2024) 307-12].

The Journal of frailty & aging·2025
Same author

Implementing Occupational Therapy into an Acute Geriatric Ward: Effects on Patients' Functional Status at Discharge.

The Journal of frailty & aging·2024
Same author

Structure of the space of folding protein sequences defined by large language models.

Physical biology·2024
Same author

Which protocol for prostate biopsies in patients with a positive MRI? Interest of systematic biopsies by sectors.

Prostate cancer and prostatic diseases·2023
Same author

Pulmonary Arterial Pruning and Longitudinal Change in Percent Emphysema and Lung Function: The Genetic Epidemiology of COPD Study.

Chest·2021

Lowering LDL cholesterol significantly reduces coronary artery disease (CAD) events. However, other lipoproteins and non-lipid factors also play crucial roles in preventing cardiac events, suggesting broader therapeutic targets.

Area of Science:

  • Cardiovascular Medicine
  • Lipid Metabolism
  • Atherosclerosis Research

Background:

  • Lowering LDL cholesterol (LDL-C) is a cornerstone in managing hypercholesterolemia and preventing coronary artery disease (CAD).
  • Recent evidence suggests LDL-C reduction alone does not fully explain the benefits of lipid-lowering therapies.
  • The role of other lipoproteins and non-lipid factors in CAD progression is increasingly recognized.

Purpose of the Study:

  • To explore the contribution of triglyceride-rich lipoproteins (VLDL, IDL), HDL, and small, dense LDL to CAD regression.
  • To identify potential therapeutic targets beyond LDL-C for CAD prevention.
  • To understand the role of non-lipid risk factors in atherosclerotic plaque stabilization.

Main Methods:

  • Analysis of large-scale CAD prevention trials.

Related Experiment Videos

  • Review of emerging evidence on lipoprotein metabolism and function.
  • Investigation of enzymatic pathways linking different lipoprotein classes.

    • Main Results:

    • Lipid-lowering therapy's benefits extend beyond LDL-C reduction.
    • Triglyceride-rich lipoproteins, HDL, and small, dense LDL influence atherosclerotic plaque stability.
    • Non-lipid risk factors are implicated in CAD event reduction.

    Conclusions:

    • Focusing solely on LDL-C levels may not be sufficient for comprehensive CAD prevention.
    • Enzymes mediating lipoprotein interrelationships are potential therapeutic targets.
    • Altering lipoprotein composition and properties offers novel strategies for CAD management.